Microcide Pharmaceuticals (MCDE) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Microcide Pharmaceuticals (MCDE)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mark Adams who wrote (139)	2/1/1998 11:39:00 PM
From: Pseudo Biologist	Read Replies (4) of 186

Mark, in retrospect I am not quite sure if Cubist was actually mentioned in the MIT Tech Review article; Microcide was for sure. Microcide's Bostian was cited in a couple of places. Another medium-big pharma mentioned was Pharmacia-Upjohn. Another approach, being pursued at the moment by a couple of private start-ups, is the use of bacteriophage viruses to kill specific bacteria. The problem, as with many viruses, is that they tend to have very specific hosts, and thus I has to know what kind of bacteria is causing the trouble before deciding if your particular brand of phage would work. Not exactly "broad spectrum." Not clear from the article if technology could obviate some of these issues. Sorry for the potential confusion on Cubist. PB

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next